Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Oncotarget|January 23, 2015
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaZiming Du, Malak Abedalthagafi, Ayal A Aizer, et al.
Journal of the National Cancer Institute|October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted TherapyPriscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Neuro-Oncology|June 4, 2014
Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningiomaAyal A Aizer, Nils D Arvold, Paul Catalano, et al.
NPJ Genomic Medicine|July 18, 2017
Genomic landscape of high-grade meningiomasWenya Linda Bi, Noah F Greenwald, Malak Abedalthagafi, et al.
NPJ Genomic Medicine|December 22, 2017
Erratum: Genomic landscape of high-grade meningiomasWenya Linda Bi, Noah F Greenwald, Malak Abedalthagafi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 29, 2020
Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapyFrancisco Del Caño-Ochoa, Bobby G Ng, Malak Abedalthagafi, et al.
Neuro-Oncology|January 31, 2016
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningiomaMalak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, et al.
Pageof 8